Ads
related to: chemotherapy stomach cancer survival rate- Clinical Trial Results
Learn About Your Diagnosis & View
Results From A Clinical Study.
- Official Patient Site
See If A HER2+ Advanced Stomach
Cancer Treatment Is An Option.
- Resources & Support
Downloadable Resources & A Support
Program Are Available. Learn More.
- Safety Information
View Potential Risks Of A HER2+
Advanced Stomach Cancer Therapy.
- Clinical Trial Results
Search results
Results From The WOW.Com Content Network
The use of chemotherapy to treat stomach cancer has no firmly established standard of care. [13] Unfortunately, stomach cancer has not been particularly sensitive to these drugs, and chemotherapy, if used, has usually served to palliatively reduce the size of the tumor, relieve symptoms of the disease, and increase survival time. [13]
Cancer of the stomach, also called gastric cancer, is the fourth-most-common type of cancer and the second-highest cause of cancer death globally. [2] Eastern Asia (China, Japan, Korea, Mongolia) is a high-risk area for gastric cancer, and North America, Australia, New Zealand and western and northern Africa are areas with low risk. [5]
In the United States there has been an increase in the 5-year relative survival rate between people diagnosed with cancer in 1975-1977 (48.9%) and people diagnosed with cancer in 2007-2013 (69.2%); these figures coincide with a 20% decrease in cancer mortality from 1950 to 2014. [8]
Age adjusted mortality rates per 100,000 people, 2013-2017. [1] All Cancer: 158.3 Oral cancer: 0.0 Esophageal cancer: 3.9 Stomach cancer: 3.1 Colorectal cancer: 13.9 Liver cancer and bile duct cancer: 6.6 Gallbladder cancer: 0.6 Pancreatic cancer: 11.0 Laryngeal cancer: 1.0 Lung cancer: 40.2 Tracheal cancer (including other respiratory organs) 0.1
Chemotherapy has relatively poor curative efficacy in SRCC patients and overall survival rates are lower compared to patients with more typical cancer pathology. SRCC cancers are usually diagnosed during the late stages of the disease, so the tumors generally spread more aggressively than non-signet cancers, making treatment challenging. [19]
New data shows that more than half (58 per cent) of those people diagnosed with lung, liver, brain, oesophagus, pancreas or stomach cancer will die from their disease within 12 months, and they ...
Ad
related to: chemotherapy stomach cancer survival rate